Sena Nomak - Co-Founder and Chief Operating Officer @ RS Research

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Sena Nomak is the Co-Founder and COO at RS Research.

Number of Investments

invested in

obfuscation

. This investment -

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	PhiTech Bioinformatics	—	Seed Round - PhiTech Bioinformatics	obfuscated obfuscation

Number of Current Board & Advisor Roles

is the

Co-Founder and Chief Operating Officer

Hub Name	CB Rank (Hub)
Pharmaceutical Early Stage Companies With Less Than $500M in Revenue	51,072
Europe, Middle East, and Africa (EMEA) Pharmaceutical Female Founded Companies	56,569
Middle East Pharmaceutical Companies	25,416
Pharmaceutical Early Stage Companies With Less Than $1B in Revenue	51,142
Biotechnology Early Stage Companies With Less Than $500M in Revenue	27,945
Europe Female Founded Companies with Early Stage Venture Funding	49,027
Turkey Companies With More Than 10 Employees (Top 10K)	8,869
City of Istanbul Startups with Female Founders	93,452
Middle East and North Africa (MENA) Early Stage Companies With More Than $1M in Revenue	53,408
Istanbul Companies With Fewer Than 50 Employees (Top 10K)	22,398

Funding Round•

Mar 22, 2023

obfuscation

from 212 and 12 other investors